Pulmonx Long Term Debt 2019-2024 | LUNG
Pulmonx Annual Long Term Debt (Millions of US $) |
|
---|---|
2023 | $35 |
2022 | $17 |
2021 | $17 |
2020 | $17 |
2019 | $15 |
2018 | $34 |
Pulmonx Quarterly Long Term Debt (Millions of US $) |
|
---|---|
2024-03-31 | $32 |
2023-12-31 | $35 |
2023-09-30 | $37 |
2023-06-30 | $37 |
2023-03-31 | $37 |
2022-12-31 | $17 |
2022-09-30 | $12 |
2022-06-30 | $14 |
2022-03-31 | $17 |
2021-12-31 | $17 |
2021-09-30 | $14 |
2021-06-30 | $15 |
2021-03-31 | $16 |
2020-12-31 | $17 |
2020-09-30 | $47 |
2020-06-30 | |
2020-03-31 | |
2019-12-31 | |
2019-09-30 | |
2018-12-31 | $34 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.325B | $0.069B |
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $36.211B | 19.88 |
Inspire Medical Systems (INSP) | United States | $4.600B | 0.00 |
Axonics (AXNX) | United States | $3.435B | 0.00 |
Hims & Hers Health (HIMS) | United States | $3.400B | 0.00 |
Olink Holding AB (publ) (OLK) | Sweden | $2.976B | 0.00 |
Enovis (ENOV) | United States | $2.744B | 20.34 |
IRhythm Technologies (IRTC) | United States | $2.738B | 0.00 |
10x Genomics (TXG) | United States | $2.735B | 0.00 |
Azenta (AZTA) | United States | $2.710B | 152.33 |
Privia Health (PRVA) | United States | $1.922B | 107.40 |
Schrodinger (SDGR) | United States | $1.586B | 0.00 |
Omnicell (OMCL) | United States | $1.456B | 50.32 |
Phreesia (PHR) | United States | $1.287B | 0.00 |
Standard BioTools (LAB) | United States | $0.965B | 0.00 |
Definitive Healthcare (DH) | United States | $0.659B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.633B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.491B | 0.00 |
Talkspace (TALK) | United States | $0.470B | 0.00 |
Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.310B | 0.00 |
Butterfly Network (BFLY) | United States | $0.217B | 0.00 |
Outset Medical (OM) | United States | $0.206B | 0.00 |
P3 Health Partners (PIII) | United States | $0.190B | 0.00 |
TruBridge (TBRG) | United States | $0.147B | 7.88 |
American Well (AMWL) | United States | $0.135B | 0.00 |
111 (YI) | China | $0.104B | 0.00 |
MSP Recovery (LIFW) | United States | $0.099B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
HeartBeam (BEAT) | United States | $0.071B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.058B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.058B | 0.00 |
Augmedix (AUGX) | United States | $0.055B | 0.00 |
Zepp Health (ZEPP) | China | $0.047B | 0.00 |
CareCloud (CCLD) | United States | $0.043B | 0.00 |
Movano (MOVE) | United States | $0.041B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
Cue Health (HLTH) | United States | $0.015B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Biotricity (BTCY) | United States | $0.011B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Syra Health (SYRA) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |